» Articles » PMID: 33485462

An Action Plan for Pan-European Defence Against New SARS-CoV-2 Variants

Citing Articles

Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study.

Clot P, Farenc C, Suratt B, Krahnke T, Tardat A, Florian P Respir Res. 2024; 25(1):107.

PMID: 38419035 PMC: 10903152. DOI: 10.1186/s12931-024-02670-z.


Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants.

Aloraij Y, Suaifan G, Shibl A, Al-Kattan K, Zourob M ACS Omega. 2023; 8(36):32877-32883.

PMID: 37720766 PMC: 10500687. DOI: 10.1021/acsomega.3c04137.


From emergency response to long-term management: the many faces of the endemic state of COVID-19.

Contreras S, Iftekhar E, Priesemann V Lancet Reg Health Eur. 2023; :100664.

PMID: 37363798 PMC: 10217566. DOI: 10.1016/j.lanepe.2023.100664.


Comprehensive mutation profiling from wastewater in southern Germany extends evidence of circulating SARS-CoV-2 diversity beyond mutations characteristic for Omicron.

Agrawal S, Orschler L, Zachmann K, Lackner S FEMS Microbes. 2023; 4:xtad006.

PMID: 37333432 PMC: 10117852. DOI: 10.1093/femsmc/xtad006.


SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics.

Berus S, Nowicka A, Wieruszewska J, Nicinski K, Kowalska A, Szymborski T Int J Mol Sci. 2023; 24(11).

PMID: 37298658 PMC: 10253828. DOI: 10.3390/ijms24119706.


References
1.
Alwan N, Burgess R, Ashworth S, Beale R, Bhadelia N, Bogaert D . Scientific consensus on the COVID-19 pandemic: we need to act now. Lancet. 2020; 396(10260):e71-e72. PMC: 7557300. DOI: 10.1016/S0140-6736(20)32153-X. View

2.
Priesemann V, Brinkmann M, Ciesek S, Cuschieri S, Czypionka T, Giordano G . Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. Lancet. 2020; 397(10269):92-93. PMC: 7833270. DOI: 10.1016/S0140-6736(20)32625-8. View

3.
Callaway E . Could new COVID variants undermine vaccines? Labs scramble to find out. Nature. 2021; 589(7841):177-178. DOI: 10.1038/d41586-021-00031-0. View